These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 26537677)

  • 1. Induction of the Lytic Cycle Sensitizes Epstein-Barr Virus-Infected B Cells to NK Cell Killing That Is Counteracted by Virus-Mediated NK Cell Evasion Mechanisms in the Late Lytic Cycle.
    Williams LR; Quinn LL; Rowe M; Zuo J
    J Virol; 2016 Jan; 90(2):947-58. PubMed ID: 26537677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr Virus BZLF1-Mediated Downregulation of Proinflammatory Factors Is Essential for Optimal Lytic Viral Replication.
    Li Y; Long X; Huang L; Yang M; Yuan Y; Wang Y; Delecluse HJ; Kuang E
    J Virol; 2016 Jan; 90(2):887-903. PubMed ID: 26537683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular STAT3 functions via PCBP2 to restrain Epstein-Barr Virus lytic activation in B lymphocytes.
    Koganti S; Clark C; Zhi J; Li X; Chen EI; Chakrabortty S; Hill ER; Bhaduri-McIntosh S
    J Virol; 2015 May; 89(9):5002-11. PubMed ID: 25717101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The switch from latent to productive infection in epstein-barr virus-infected B cells is associated with sensitization to NK cell killing.
    Pappworth IY; Wang EC; Rowe M
    J Virol; 2007 Jan; 81(2):474-82. PubMed ID: 17079298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Epstein-Barr Virus Oncogene EBNA1 Suppresses Natural Killer Cell Responses and Apoptosis Early after Infection of Peripheral B Cells.
    Westhoff Smith D; Chakravorty A; Hayes M; Hammerschmidt W; Sugden B
    mBio; 2021 Dec; 12(6):e0224321. PubMed ID: 34781735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Missing Link in Epstein-Barr Virus Immune Evasion: the BDLF3 Gene Induces Ubiquitination and Downregulation of Major Histocompatibility Complex Class I (MHC-I) and MHC-II.
    Quinn LL; Williams LR; White C; Forrest C; Zuo J; Rowe M
    J Virol; 2016 Jan; 90(1):356-67. PubMed ID: 26468525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular differentiation regulator BLIMP1 induces Epstein-Barr virus lytic reactivation in epithelial and B cells by activating transcription from both the R and Z promoters.
    Reusch JA; Nawandar DM; Wright KL; Kenney SC; Mertz JE
    J Virol; 2015 Feb; 89(3):1731-43. PubMed ID: 25410866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus evades CD4+ T cell responses in lytic cycle through BZLF1-mediated downregulation of CD74 and the cooperation of vBcl-2.
    Zuo J; Thomas WA; Haigh TA; Fitzsimmons L; Long HM; Hislop AD; Taylor GS; Rowe M
    PLoS Pathog; 2011 Dec; 7(12):e1002455. PubMed ID: 22216005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactivation of lytic replication from B cells latently infected with Epstein-Barr virus occurs with high S-phase cyclin-dependent kinase activity while inhibiting cellular DNA replication.
    Kudoh A; Fujita M; Kiyono T; Kuzushima K; Sugaya Y; Izuta S; Nishiyama Y; Tsurumi T
    J Virol; 2003 Jan; 77(2):851-61. PubMed ID: 12502801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr Virus MicroRNA miR-BART20-5p Suppresses Lytic Induction by Inhibiting BAD-Mediated caspase-3-Dependent Apoptosis.
    Kim H; Choi H; Lee SK
    J Virol; 2016 Feb; 90(3):1359-68. PubMed ID: 26581978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of activation of the BNLF2a immune evasion gene of Epstein-Barr virus by Zta.
    Almohammed R; Osborn K; Ramasubramanyan S; Perez-Fernandez IBN; Godfrey A; Mancini EJ; Sinclair AJ
    J Gen Virol; 2018 Jun; 99(6):805-817. PubMed ID: 29580369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone Loaders CAF1 and HIRA Restrict Epstein-Barr Virus B-Cell Lytic Reactivation.
    Zhang Y; Jiang C; Trudeau SJ; Narita Y; Zhao B; Teng M; Guo R; Gewurz BE
    mBio; 2020 Oct; 11(5):. PubMed ID: 33109754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BZLF1 Attenuates Transmission of Inflammatory Paracrine Senescence in Epstein-Barr Virus-Infected Cells by Downregulating Tumor Necrosis Factor Alpha.
    Long X; Li Y; Yang M; Huang L; Gong W; Kuang E
    J Virol; 2016 Sep; 90(17):7880-93. PubMed ID: 27334596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secreted Oral Epithelial Cell Membrane Vesicles Induce Epstein-Barr Virus Reactivation in Latently Infected B Cells.
    Lin Z; Swan K; Zhang X; Cao S; Brett Z; Drury S; Strong MJ; Fewell C; Puetter A; Wang X; Ferris M; Sullivan DE; Li L; Flemington EK
    J Virol; 2016 Jan; 90(7):3469-79. PubMed ID: 26764001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional Epstein-Barr virus reservoir in plasma cells derived from infected peripheral blood memory B cells.
    Al Tabaa Y; Tuaillon E; Bollore K; Foulongne V; Petitjean G; Seigneurin JM; Duperray C; Desgranges C; Vendrell JP
    Blood; 2009 Jan; 113(3):604-11. PubMed ID: 18845794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct killing of Epstein-Barr virus (EBV)-infected B cells by CD4 T cells directed against the EBV lytic protein BHRF1.
    Landais E; Saulquin X; Scotet E; Trautmann L; Peyrat MA; Yates JL; Kwok WW; Bonneville M; Houssaint E
    Blood; 2004 Feb; 103(4):1408-16. PubMed ID: 14563644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr Virus miR-BHRF1-3 Targets the BZLF1 3'UTR and Regulates the Lytic Cycle.
    Fachko DN; Chen Y; Skalsky RL
    J Virol; 2022 Feb; 96(4):e0149521. PubMed ID: 34878852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceramide promotes lytic reactivation of Epstein-Barr virus in gastric carcinoma.
    Kim JY; Min YJ; Lee M-H; An YR; Ashktorab H; Smoot DT; Kwon SW; Lee SK
    J Virol; 2024 Feb; 98(2):e0177623. PubMed ID: 38197630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valpromide Inhibits Lytic Cycle Reactivation of Epstein-Barr Virus.
    Gorres KL; Daigle D; Mohanram S; McInerney GE; Lyons DE; Miller G
    mBio; 2016 Mar; 7(2):e00113. PubMed ID: 26933051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease.
    Chiang AK; Tao Q; Srivastava G; Ho FC
    Int J Cancer; 1996 Nov; 68(3):285-90. PubMed ID: 8903467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.